Top

Reactions Weekly

Published in:

01-04-2021 | Nephroblastoma | Case report

Conjugated estrogens/estradiol

Pelvic seromucinous borderline tumour secondary to endometriotic cyst: case report

Published in: Reactions Weekly | Issue 1/2021

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Uehara T, et al. Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy. Gynecologic Oncology Reports 35: Feb 2021. Available from: URL: http://doi.org/10.1016/j.gore.2020.100692

Title: Conjugated estrogens/estradiol
Pelvic seromucinous borderline tumour secondary to endometriotic cyst: case report
Publication date: 01-04-2021
Publisher: Springer International Publishing
Keywords: Nephroblastoma
Endometriosis
Estrogens
Estradiol
Published in: Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-94208-9

At a glance: The STEP trials

Springer Medicine

Conjugated estrogens/estradiol

Pelvic seromucinous borderline tumour secondary to endometriotic cyst: case report

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Cemiplimab

Antineoplastics

Carbimazole

Lenvatinib

Everolimus/trastuzumab

Antibacterials/glucose/olive-oil/soya-oil-emulsion